CD44 and breast carcinoma: Markers consistently altered at lower bufalin concentrations (20 nM) were C-Kit, the CSC marker ALDH1A1, and the EMT factor Slug, which has previously been shown to be a regulator of CD44+ CSCs in breast cancer [25].